Oppenheimer & CO Inc Exact Sciences Corp Transaction History

Oppenheimer & CO Inc

$6.42 Billion
Q3 2024

A detailed history of Oppenheimer & CO Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Oppenheimer & CO Inc holds 24,484 shares of EXAS stock, worth $1.48 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

24,484

Previous 24,360 0.51%

Holding current value

$1.48 Million

Previous $1.03 Million 62.0%

% of portfolio

0.03%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$42.43 - $70.83 $5,261 - $8,782	124 Added 0.51%	24,484 $1.67 Million
Q2 2024 Aug 07, 2024	BUY	$41.33 - $74.26 $52,571 - $94,458	1,272 Added 5.51%	24,360 $1.03 Million
Q1 2024 May 06, 2024	BUY	$56.27 - $73.77 $22,564 - $29,581	401 Added 1.77%	23,088 $1.59 Million
Q4 2023 Feb 13, 2024	BUY	$59.06 - $75.72 $60,241 - $77,234	1,020 Added 4.71%	22,687 $1.68 Million
Q3 2023 Nov 07, 2023	BUY	$65.94 - $99.04 $2,110 - $3,169	32 Added 0.15%	21,667 $1.48 Million
Q2 2023 Aug 02, 2023	BUY	$62.68 - $95.05 $46,821 - $71,002	747 Added 3.58%	21,635 $2.03 Million
Q1 2023 May 10, 2023	BUY	$47.19 - $70.77 $12,410 - $18,612	263 Added 1.28%	20,888 $1.42 Million
Q4 2022 Feb 07, 2023	SELL	$30.35 - $53.15 $225,712 - $395,276	-7,437 Reduced 26.5%	20,625 $1.02 Million
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $166,755 - $257,513	5,216 Added 22.83%	28,062 $912,000
Q2 2022 Aug 08, 2022	BUY	$35.61 - $76.23 $248,557 - $532,085	6,980 Added 43.99%	22,846 $900,000
Q1 2022 May 12, 2022	SELL	$57.56 - $82.54 $178,090 - $255,378	-3,094 Reduced 16.32%	15,866 $1.11 Million
Q4 2021 Feb 02, 2022	SELL	$72.5 - $100.68 $95,990 - $133,300	-1,324 Reduced 6.53%	18,960 $1.48 Million
Q3 2021 Nov 12, 2021	SELL	$90.24 - $124.05 $375,037 - $515,551	-4,156 Reduced 17.0%	20,284 $1.94 Million
Q2 2021 Aug 03, 2021	BUY	$93.66 - $139.27 $155,756 - $231,606	1,663 Added 7.3%	24,440 $3.04 Million
Q1 2021 May 10, 2021	BUY	$116.57 - $155.01 $696,855 - $926,649	5,978 Added 35.59%	22,777 $3 Million
Q4 2020 Feb 11, 2021	BUY	$99.61 - $142.12 $1.26 Million - $1.8 Million	12,675 Added 307.35%	16,799 $2.23 Million
Q3 2020 Nov 13, 2020	SELL	$72.92 - $102.01 $640,529 - $896,055	-8,784 Reduced 68.05%	4,124 $420,000
Q2 2020 Aug 11, 2020	BUY	$55.75 - $92.75 $44,042 - $73,272	790 Added 6.52%	12,908 $1.12 Million
Q1 2020 May 08, 2020	BUY	$37.9 - $104.44 $459,272 - $1.27 Million	12,118 New	12,118 $703,000
Q3 2019 Oct 31, 2019	SELL	$90.37 - $122.49 $505,620 - $685,331	-5,595 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$89.51 - $118.04 $511,012 - $673,890	-5,709 Reduced 50.5%	5,595 $660,000
Q1 2019 Apr 24, 2019	BUY	$61.98 - $96.5 $700,621 - $1.09 Million	11,304 New	11,304 $979,000
Q2 2018 Aug 10, 2018	SELL	$37.84 - $69.96 $285,389 - $527,638	-7,542 Closed	0 $0
Q1 2018 May 01, 2018	BUY	$39.82 - $57.53 $300,322 - $433,891	7,542 New	7,542 $304,000

Others Institutions Holding EXAS

# of Institutions

674

Shares Held

163M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.7B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Account

Oppenheimer & CO Inc Exact Sciences Corp Transaction History